{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:53:17Z","timestamp":1774968797267,"version":"3.50.1"},"reference-count":155,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>COVID-19 infection has protean systemic manifestations. Experience from previous coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of thrombosis of both macrovasculature and microvasculature. The former involves both arterial and venous beds manifesting as stroke, acute coronary syndrome and venous thromboembolic events. The microvascular thrombosis is an underappreciated complication of SARS-CoV-2 infection with profound implications on the development of multisystem organ failure. The telltale signs of perpetual on-going coagulation and fibrinolytic cascades underscore the presence of diffuse endothelial damage in the patients with COVID-19. These parameters serve as strong predictors of mortality. While summarizing the alterations of various components of thrombosis in patients with COVID-19, this review points to the emerging evidence that implicates the prominent role of the extrinsic coagulation cascade in COVID-19-related coagulopathy. These mechanisms are triggered by widespread endothelial cell damage (endotheliopathy), the dominant driver of macro- and micro-vascular thrombosis in these patients. We also summarize other mediators of thrombosis, clinically relevant nuances such as the occurrence of thromboembolic events despite thromboprophylaxis (breakthrough thrombosis), current understanding of systemic anticoagulation therapy and its risk\u2013benefit ratio. We conclude by emphasizing a need to probe COVID-19-specific mechanisms of thrombosis to develop better risk markers and safer therapeutic targets.<\/jats:p>","DOI":"10.3390\/cells9112392","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T21:39:56Z","timestamp":1604180396000},"page":"2392","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hyperthrombotic Milieu in COVID-19 Patients"],"prefix":"10.3390","volume":"9","author":[{"given":"Mohamed Hassan","family":"Kamel","sequence":"first","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqing","family":"Yin","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Zavaro","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Francis","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipul C.","family":"Chitalia","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA"},{"name":"Veterans Affairs Boston Healthcare System, Boston, MA 02132, USA"},{"name":"Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"m408","DOI":"10.1136\/bmj.m408","article-title":"China coronavirus: WHO declares international emergency as death toll exceeds 200","volume":"368","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/JVI.00697-06","article-title":"Prevalence and genetic diversity of coronaviruses in bats from China","volume":"80","author":"Tang","year":"2006","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diagmicrobio.2018.10.011","article-title":"MERS coronavirus outbreak: Implications for emerging viral infections","volume":"93","author":"Rabaan","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/01.PDR.0000129184.87042.FC","article-title":"SARS: The first pandemic of the 21st century","volume":"56","author":"Cherry","year":"2004","journal-title":"Pediatr. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/JVI.02605-06","article-title":"Evolutionary insights into the ecology of coronaviruses","volume":"81","author":"Vijaykrishna","year":"2007","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Daly, J.L., Simonetti, B., Ant\u00f3n-Pl\u00e1garo, C., Williamson, M.K., Shoemark, D.K., Sim\u00f3n-Gracia, L., Klein, K., Bauer, M., Hollandi, R., and Greber, U.F. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. bioRxiv.","DOI":"10.1101\/2020.06.05.134114"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wang, K., Chen, W., Zhou, Y.-S., Lian, J.-Q., Zhang, Z., Du, P., Gong, L., Zhang, Y., Cui, H.-Y., and Geng, J.-J. (2020). SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv.","DOI":"10.1101\/2020.03.14.988345"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Amraie, R., Napoleon, M.A., Yin, W., Berrigan, J., Suder, E., Zhao, G., Olejnik, J., Gummuluru, S., Muhlberger, E., and Chitalia, V. (2020). Vipul Chitalia CD209L\/L-SIGN and CD209\/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells. bioRxiv.","DOI":"10.1101\/2020.06.22.165803"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","article-title":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China","volume":"26","author":"Wu","year":"2020","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and Multiorgan Response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection","volume":"58","author":"Han","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1126\/science.145.3638.1310","article-title":"Waterfall Sequence for Intrinsic Blood Clotting","volume":"145","author":"Davie","year":"1964","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/202498a0","article-title":"An Enzyme Cascade in the Blood Clotting Mechanism, and Its Function as a Biochemical Amplifier","volume":"202","author":"Macfarlane","year":"1964","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","article-title":"Tissue factor in cardiovascular diseases: Molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0049-3848(08)70018-5","article-title":"Tissue factor activity and function in blood coagulation","volume":"122","author":"Butenas","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4065\/82.7.864","article-title":"How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults","volume":"82","author":"Kamal","year":"2007","journal-title":"Mayo. Clin. Proc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System Part I\u2014Molecular Mechanisms of Activation and Regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement System Part II: Role in Immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V100.2.517","article-title":"C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils","volume":"100","author":"Wojta","year":"2002","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000083842","article-title":"New aspects in thrombotic research: Complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype","volume":"33","author":"Wojta","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-62703-339-8_1","article-title":"The coagulation system in humans","volume":"992","author":"Chan","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/00365540310015638","article-title":"Interactions between coagulation and inflammation","volume":"35","author":"Opal","year":"2003","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2174\/157016112801784549","article-title":"Crosstalk between inflammation and coagulation: The lessons of sepsis","volume":"10","author":"Levi","year":"2012","journal-title":"Curr. Vasc. Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/978-3-642-79735-4_8","article-title":"Clotting and immune defense in Limulidae","volume":"15","author":"Muta","year":"1996","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1538-7836.2011.04323.x","article-title":"Innate immunity and coagulation","volume":"9","author":"Esmon","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/rth2.12109","article-title":"The coagulation system in host defense","volume":"2","author":"Antoniak","year":"2018","journal-title":"Res Pr. Thromb Haemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.immuni.2019.03.003","article-title":"The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1alpha by Thrombin","volume":"50","author":"Burzynski","year":"2019","journal-title":"Immunity"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00281-017-0637-x","article-title":"Molecular pathogenesis of viral hemorrhagic fever","volume":"39","author":"Basler","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.003","article-title":"Varicella-zoster vasculitis presenting with cerebellar hemorrhage","volume":"24","author":"Matsuo","year":"2015","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, W., Ruan, Q.L., Yan, F., and Hu, Y.K. (2020). Fatal hemorrhagic varicella in a patient with abdominal pain: A case report. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-019-4716-6"},{"key":"ref_45","first-page":"151","article-title":"Hemorrhagic complications of varicella","volume":"35","author":"Maness","year":"1987","journal-title":"Am. Fam. Phys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ajh.25386","article-title":"Purpura fulminans from reduced protein S following cytomegalovirus and varicella infection","volume":"94","author":"Fonkoua","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.4081\/idr.2014.5512","article-title":"Massive Alimentary Tract Bleeding due to Cytomegalovirus Infection in an Elderly Patient","volume":"6","author":"Koc","year":"2014","journal-title":"Infect. Dis. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MAJ.0b013e31812f5ba5","article-title":"Association between cytomegalovirus infection and venous thromboembolism","volume":"334","author":"Fridlender","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/1971400915609349","article-title":"Epstein-Barr virus encephalitis presenting as cerebellar hemorrhage","volume":"28","author":"Sabat","year":"2015","journal-title":"Neuroradiol. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jmv.23354","article-title":"Review: Viral infections and mechanisms of thrombosis and bleeding","volume":"84","author":"Goeijenbier","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-0711-4-11","article-title":"Acute cytomegalovirus infection complicated by venous thrombosis: A case report","volume":"4","author":"Rovery","year":"2005","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-3476(95)70355-1","article-title":"Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection","volume":"126","author":"Reif","year":"1995","journal-title":"J. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/clinids\/24.2.197","article-title":"Antiphospholipid syndrome associated with cytomegalovirus infection: Case report and review","volume":"24","author":"Labarca","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00415-004-0519-8","article-title":"Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)","volume":"251","author":"Umapathi","year":"2004","journal-title":"J. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/bjh.16760","article-title":"Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19","volume":"189","author":"Vulliamy","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_58","first-page":"001690","article-title":"Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection","volume":"7","author":"Lia","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Griffin, D.O., Jensen, A., Khan, M., Chin, J., Chin, K., Parnell, R., Awwad, C., and Patel, D. (2020). Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis. Br. J. Haematol.","DOI":"10.1111\/bjh.16792"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/2229-5151.141435","article-title":"D Dimer in acute care","volume":"4","author":"Sathe","year":"2014","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Xie, Y., Wang, X., Yang, P., and Zhang, S. (2020). COVID-19 Complicated by Acute Pulmonary Embolism. Radiol. Cardiothorac. Imaging, 2.","DOI":"10.1148\/ryct.2020200067"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jvsv.2020.04.004","article-title":"Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations","volume":"8","author":"Marone","year":"2020","journal-title":"J. Vasc. Surg. Venous. Lymphat. Disord."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: A random association?","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_66","first-page":"001646","article-title":"Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?","volume":"7","author":"Poggiali","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/ijlh.12665","article-title":"Review of D-dimer testing: Good, Bad, and Ugly","volume":"39","author":"Linkins","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","article-title":"COVID-19 Does Not Lead to a \u201cTypical\u201d Acute Respiratory Distress Syndrome","volume":"201","author":"Gattinoni","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wichmann, D., Sperhake, J.-P., L\u00fctgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., and Schr\u00f6der, A.S. (2020). Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann. Intern. Med., 18.","DOI":"10.7326\/M20-2003"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"Dolhnikoff","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","volume":"123","author":"White","year":"2009","journal-title":"Thromb. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1161\/CIRCULATIONAHA.113.006472","article-title":"Racial and regional differences in venous thromboembolism in the United States in 3 cohorts","volume":"129","author":"Zakai","year":"2014","journal-title":"Circulation"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2020.6548","article-title":"COVID-19 and African Americans","volume":"323","author":"Yancy","year":"2020","journal-title":"JAMA"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Wright, J.E., and Merritt, C.C. (2020). Social Equity and COVID-19: The Case of African Americans. Public Adm. Rev.","DOI":"10.2139\/ssrn.3610987"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e19934","DOI":"10.2196\/19934","article-title":"Why African Americans Are a Potential Target for COVID-19 Infection in the United States","volume":"22","author":"Hamidianjahromi","year":"2020","journal-title":"J. Med. Internet. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1076029620943671","DOI":"10.1177\/1076029620943671","article-title":"Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19","volume":"26","author":"Frydman","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: An autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2213-2600(20)30244-7","article-title":"Increased cardiovascular mortality in African Americans with COVID-19","volume":"8","author":"McGonagle","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00134-020-06059-6","article-title":"Facing COVID-19 in the ICU: Vascular dysfunction, thrombosis, and dysregulated inflammation","volume":"46","author":"Leisman","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Menter, T., Haslbauer, J.D., Nienhold, R., Savic, S., Deigendesch, H., Frank, S., Turek, D., Willi, N., Pargger, H., and Bassetti, S. (2020). Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology.","DOI":"10.1111\/his.14134"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Fox, S.E., Akmatbekov, A., Harbert, J.L., Li, G., Brown, J.Q., and Vander Heide, R.S. (2020). Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. medRxiv.","DOI":"10.1101\/2020.04.06.20050575"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Goshua, G., Pine, A.B., Meizlish, M.L., Chang, C.H., Zhang, H., Bahel, P., Baluha, A., Bar, N., Bona, R.D., and Burns, A.J. (2020). Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study. Lancet Haematol.","DOI":"10.1016\/S2352-3026(20)30216-7"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"190","author":"Escher","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_90","first-page":"1861","article-title":"Clinical Characteristics of Covid-19 in China. Reply","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Di Micco, P., Russo, V., Carannante, N., Imparato, M., Rodolfi, S., Cardillo, G., and Lodigiani, C. (2020). Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051371"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan, J.M., Gonagle, D.M., Ward, S.E., Preston, R.J.S., and O\u2019Donnell, J.S. (2020). Endothelial cells orchestrate COVID-19 coagulopathy. Lancet Haematol.","DOI":"10.1016\/S2352-3026(20)30215-5"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Amraei, R., and Rahimi, N. (2020). COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells, 9.","DOI":"10.3390\/cells9071652"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","article-title":"How I treat disseminated intravascular coagulation","volume":"131","author":"Levi","year":"2018","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Gordon, D.E., Jang, G.M., Bouhaddou, M., Xu, J., Obernier, K., O\u2019Meara, M.J., Guo, J.Z., Swaney, D.L., Tummino, T.A., and Huttenhain, R. (2020). A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. bioRxiv.","DOI":"10.1101\/2020.03.22.002386"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.0608647104","article-title":"Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation","volume":"104","author":"Kannemeier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"105051","DOI":"10.1016\/j.phrs.2020.105051","article-title":"Targeting inflammation and cytokine storm in COVID-19","volume":"159","author":"Huang","year":"2020","journal-title":"Pharm. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Wright, D.J.M. (2020). Prevention of the cytokine storm in COVID-19. Lancet Infect. Dis.","DOI":"10.1016\/S1473-3099(20)30376-5"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Ye, Q., Wang, B., and Mao, J. (2020). The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J. Infect.","DOI":"10.1016\/j.jinf.2020.03.037"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ. Res."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Wan, S., Yi, Q., Fan, S., Lv, J., Zhang, X., Guo, L., Lang, C., Xiao, Q., Xiao, K., and Yi, Z. (2020). Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv.","DOI":"10.1101\/2020.02.10.20021832"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1055\/s-0038-1650653","article-title":"Interleukin-6 stimulates coagulation, not fibrinolysis, in humans","volume":"76","author":"Stouthard","year":"1996","journal-title":"Thromb. Haemost."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_113","first-page":"92","article-title":"Inhibition of tissue factor and cytokine release","volume":"26","author":"Gray","year":"1996","journal-title":"Haemostasis"},{"key":"ref_114","first-page":"495","article-title":"Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects","volume":"10","author":"Friederich","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41577-020-0314-5","article-title":"Coronaviruses hijack the complement system","volume":"20","author":"Wilk","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Gralinski, L.E., Sheahan, T.P., Morrison, T.E., Menachery, V.D., Jensen, K., Leist, S.R., Whitmore, A., Heise, M.T., and Baric, R.S. (2018). Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio, 9.","DOI":"10.1128\/mBio.01753-18"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0002-9440(10)61133-9","article-title":"Anti-c5a ameliorates coagulation\/fibrinolytic protein changes in a rat model of sepsis","volume":"160","author":"Laudes","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Li, J., Guo, M., Tian, X., Wang, X., Yang, X., Wu, P., Liu, C., Xiao, Z., Qu, Y., and Yin, Y. (2020). Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. BioRxiv, 10.","DOI":"10.1101\/2020.03.31.019216"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Gao, T., Hu, M., Zhang, X., Li, H., Zhu, L., Liu, H., Dong, Q., Zhang, Z., Wang, Z., and Hu, Y. (2020). Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. medRxiv, 10.","DOI":"10.1101\/2020.03.29.20041962"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19?","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.blre.2017.07.006","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"31","author":"Chaturvedi","year":"2017","journal-title":"Blood Rev."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Harzallah, I., Debliquis, A., and Drenou, B. (2020). Lupus anticoagulant is frequent in patients with Covid-19. J. Thromb. Haemost.","DOI":"10.1111\/jth.14980"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/sarh.2002.28303","article-title":"Viral infections and antiphospholipid antibodies","volume":"31","author":"Uthman","year":"2002","journal-title":"Semin. Arthritis Rheum"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann. Rheum Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1023\/B:JOCI.0000018058.28764.ce","article-title":"Antiphospholipid syndrome infectious origin","volume":"24","author":"Blank","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2020.06.008","article-title":"Mechanisms involved in the development of thrombocytopenia in patients with COVID-19","volume":"193","author":"Zhang","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jth.14848","article-title":"Thrombocytopenia and its association with mortality in patients with COVID-19","volume":"18","author":"Yang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jth.14788","article-title":"Large and small platelets-(When) do they differ?","volume":"18","author":"Handtke","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0039-1677875","article-title":"Role of Platelet Size Revisited-Function and Protein Composition of Large and Small Platelets","volume":"119","author":"Handtke","year":"2019","journal-title":"Thromb. Haemost."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"Ranucci","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Skendros, P., Mitsios, A., Chrysanthopoulou, A., Mastellos, D.C., Metallidis, S., Rafailidis, P., Ntinopoulou, M., Sertaridou, E., Tsironidou, V., and Tsigalou, C. (2020). Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Investig.","DOI":"10.1101\/2020.06.15.20131029"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Barnes, B.J., Adrover, J.M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J.M., Dassler-Plenker, J., Guerci, P., Huynh, C., and Knight, J.S. (2020). Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J. Exp. Med., 217.","DOI":"10.1084\/jem.20200652"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Bikdeli, B., Madhavan, M.V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C., Ageno, W., Madjid, M., and Guo, Y. (2020). COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J. Am. Coll. Cardiol.","DOI":"10.1016\/j.jacc.2020.04.031"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2017.10.012","article-title":"Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism prevention","volume":"160","author":"Popoola","year":"2017","journal-title":"Thromb. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1160\/TH16-08-0595","article-title":"Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials","volume":"117","author":"Dentali","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0039-3400302","article-title":"Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment","volume":"120","author":"Schindewolf","year":"2020","journal-title":"Thromb. Haemost."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-019-2587-2","article-title":"Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): An updated meta-analysis","volume":"23","author":"Yamakawa","year":"2019","journal-title":"Crit. Care"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40560-014-0051-6","article-title":"Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation","volume":"2","author":"Iba","year":"2014","journal-title":"J. Intensive Care"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Java, A., Apicelli, A.J., Liszewski, M.K., Coler-Reilly, A., Atkinson, J.P., Kim, A.H., and Kulkarni, H.S. (2020). The complement system in COVID-19: Friend and foe?. JCI Insight.","DOI":"10.1172\/jci.insight.140711"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2020.06.027","article-title":"Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review","volume":"194","author":"Bellander","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of Coronavirus Disease 2019","volume":"48","author":"Iba","year":"2020","journal-title":"Crit. Care Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/11\/2392\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:27:41Z","timestamp":1760178461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/11\/2392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":155,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["cells9112392"],"URL":"https:\/\/doi.org\/10.3390\/cells9112392","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]}}}